MENU
+Compare
IOVA
Stock ticker: NASDAQ
AS OF
Nov 26, 04:59 PM (EDT)
Price
$2.44
Change
-$0.05 (-2.02%)
Capitalization
966.62M

IOVA Iovance Biotherapeutics Forecast, Technical & Fundamental Analysis

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology
IOVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IOVA with price predictions
Nov 25, 2025

IOVA in upward trend: price rose above 50-day moving average on November 21, 2025

IOVA moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend. In of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where IOVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IOVA just turned positive on November 24, 2025. Looking at past instances where IOVA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for IOVA crossed bullishly above the 50-day moving average on November 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IOVA advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 149 cases where IOVA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IOVA moved out of overbought territory on November 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IOVA as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IOVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IOVA broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.376) is normal, around the industry mean (27.690). P/E Ratio (0.000) is within average values for comparable stocks, (51.985). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.895). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (3.226) is also within normal values, averaging (322.277).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IOVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IOVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
IOVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IOVA is expected to report earnings to fall 28.88% to -17 cents per share on March 03

Iovance Biotherapeutics IOVA Stock Earnings Reports
Q4'25
Est.
$-0.18
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.05
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of -25 cents, beating the estimate of -26 cents. With 6.68M shares outstanding, the current market capitalization sits at 966.62M.
A.I. Advisor
published General Information

General Information

a developer of biotechnological products for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
825 Industrial Road
Phone
+1 650 260-7120
Employees
557
Web
https://www.iovance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDVRX14.690.22
+1.52%
Macquarie Value R
CMCIX25.600.37
+1.47%
Calvert Small/Mid-Cap I
HDVCX15.010.14
+0.94%
Hartford International Equity C
VHGEX41.47N/A
N/A
Vanguard Global Equity Inv
RIEIX13.13N/A
N/A
RBC International Equity I

IOVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with PLX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then PLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-0.80%
PLX - IOVA
44%
Loosely correlated
+2.29%
CLDX - IOVA
44%
Loosely correlated
+0.46%
VCYT - IOVA
43%
Loosely correlated
+5.74%
IDYA - IOVA
43%
Loosely correlated
+2.37%
ROIV - IOVA
41%
Loosely correlated
+2.76%
More